ArticleScientific reports2018

Author Correction: Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial.

Masaya Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.